Cargando…
Thwarting galectin-induced immunosuppression in breast cancer
Novel therapeutic strategies are needed to counteract breast cancer-associated immunosuppression. Silencing the expression of galectin-1 in a breast carcinoma model inhibited tumor growth and prevented lung metastasis by reducing the frequency and immunosuppressive activity of CD4(+)CD25(+) FOXP3(+)...
Autores principales: | Salatino, Mariana, Dalotto-Moreno, Tomas, Rabinovich, Gabriel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667902/ https://www.ncbi.nlm.nih.gov/pubmed/23762796 http://dx.doi.org/10.4161/onci.24077 |
Ejemplares similares
-
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
por: Girotti, María Romina, et al.
Publicado: (2019) -
Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013) -
Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
por: Gordon-Alonso, Monica, et al.
Publicado: (2014) -
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
por: Croci, Diego O, et al.
Publicado: (2014) -
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells
por: Faget, Julien, et al.
Publicado: (2013)